{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:48:23Z","timestamp":1782996503772,"version":"3.54.5"},"reference-count":122,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2021,2,9]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>The available scientific literature regarding tanshinones is very abundant, and after its review,\nit is noticeable that most of the articles focus on the properties of tanshinone I, cryptotanshinone,\ntanshinone IIA, sodium tanshinone IIA sulfonate and the dried root extract of Salvia miltiorrhiza (Tan-\nShen). However, although these products have demonstrated important biological properties in both in\nvitro and in vivo models, their poor solubility and bioavailability have limited their clinical applications.\nFor these reasons, many studies have focused on the search for new pharmaceutical formulations\nfor tanshinones, as well as the synthesis of new derivatives that improve their biological properties. To\nprovide new insights into the critical path ahead, we systemically reviewed the most recent advances\n(reported since 2015) on tanshinones in scientific databases (PubMed, Web of Science, Medline, Scopus,\nand Clinical Trials). With a broader perspective, we offer an update on the last five years of new\nresearch on these quinones, focusing on their synthesis, biological activity on noncommunicable diseases\nand drug delivery systems, to support future research on its clinical applications.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557520666200429103225","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T16:52:15Z","timestamp":1588179135000},"page":"171-185","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Tanshinones and their Derivatives: Heterocyclic Ring-Fused Diterpenes of Biological Interest"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2113-0627","authenticated-orcid":true,"given":"Arturo","family":"Estolano-Cobi\u00e1n","sequence":"first","affiliation":[{"name":"Facultad de Ciencias Qui\u0131micas e Ing, Universidad Autonoma de Baja California, Clz. Universidad 14418, Parque Industrial Internacional, Tijuana, B. C. CP 22390, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6910-4583","authenticated-orcid":true,"given":"Mariana Mac\u00edas","family":"Alonso","sequence":"additional","affiliation":[{"name":"Instituto Politecnico Nacional, UPIIG, Av. Mineral de Valenciana, No. 200, Col. Fracc, Industrial Puerto Interior, C.P. 36275 Silao de la Victoria, Guanajuato, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9093-2028","authenticated-orcid":true,"given":"Laura","family":"D\u00edaz-Rubio","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias Qui\u0131micas e Ing, Universidad Autonoma de Baja California, Clz. Universidad 14418, Parque Industrial Internacional, Tijuana, B. C. CP 22390, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Naredo","family":"Ponce","sequence":"additional","affiliation":[{"name":"Instituto Politecnico Nacional, UPIIG, Av. Mineral de Valenciana, No. 200, Col. Fracc, Industrial Puerto Interior, C.P. 36275 Silao de la Victoria, Guanajuato, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5528-400X","authenticated-orcid":true,"given":"Iv\u00e1n","family":"C\u00f3rdova-Guerrero","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias Qui\u0131micas e Ing, Universidad Autonoma de Baja California, Clz. Universidad 14418, Parque Industrial Internacional, Tijuana, B. C. CP 22390, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3720-4528","authenticated-orcid":true,"given":"Joaqu\u00edn G.","family":"Marrero","sequence":"additional","affiliation":[{"name":"Instituto Politecnico Nacional, UPIIG, Av. Mineral de Valenciana, No. 200, Col. Fracc, Industrial Puerto Interior, C.P. 36275 Silao de la Victoria, Guanajuato, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1021\/cr200058f","volume":"112","author":"Wu Y.B.","year":"2012","unstructured":"Wu Y.B.; Ni Z.Y.; Shi Q.W.; Dong M.; Kiyota H.; Gu Y.C.; Cong B.; Constituents from Salvia species and their biological activities. Chem Rev 2012,112(11),5967-6026","journal-title":"Chem Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1016\/S0040-4039(00)89532-5","volume":"9","author":"Kakisawa H.","year":"1968","unstructured":"Kakisawa H.; Hayashi T.; Okazaki I.; Ohashi M.; Isolation and structures of new tanshinones. Tetrahedron Lett 1968,9,3231-3234","journal-title":"Tetrahedron Lett"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"In: Yan, X., Ed.; Biology and Chemistry, 1st ed; Dan Shen (Salvia miltiorrhiza) in Medicine. In: Yan, X., Ed.; Biology and Chemistry, 1st ed; Springer: Netherlands, 2015; 1, .","DOI":"10.1007\/978-94-017-9463-3"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1039\/c0np00035c","volume":"28","author":"Dong Y.","year":"2011","unstructured":"Dong Y.; Morris-Natschke S.L.; Lee K.H.; Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents. Nat Prod Rep 2011,28(3),529-542","journal-title":"Nat Prod Rep"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/S0140-6736(15)00516-4","volume":"387","author":"Beard J.R.","year":"2016","unstructured":"Beard J.R.; Officer A.; de Carvalho I.A.; Sadana R.; Pot A.M.; Michel J.P.; Lloyd-Sherlock P.; Epping-Jordan J.E.; Peeters G.M.E.E.G.; Mahanani W.R.; Thiyagarajan J.A.; Chatterji S.; The World report on ageing and health: A policy framework for healthy ageing. Lancet 2016,387(10033),2145-2154","journal-title":"Lancet"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2217\/nnm.15.185","volume":"11","author":"Cai Y.","year":"2016","unstructured":"Cai Y.; Zhang W.; Chen Z.; Shi Z.; He C.; Chen M.; Recent insights into the biological activities and drug delivery systems of tanshinones. Int J Nanomedicine 2016,11,121-130","journal-title":"Int J Nanomedicine"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1055\/s-0035-1546196","volume":"81","author":"Bonaccini L.","year":"2015","unstructured":"Bonaccini L.; Karioti A.; Bergonzi M.C.; Bilia A.R.; Effects of Salvia miltiorrhiza on CNS neuronal injury and degeneration: A plausible complementary role of tanshinones and depsides. Planta Med 2015,81(12-13),1003-1016","journal-title":"Planta Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1248\/cpb.53.1524","volume":"53","author":"Marrero J.G.","year":"2005","unstructured":"Marrero J.G.; Andr\u00e9s L.S.; Luis J.G.; Quinone derivatives by chemical transformations of 16-hydroxycarnosol from Salvia species. Chem Pharm Bull (Tokyo) 2005,53(12),1524-1529","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1016\/j.tet.2014.03.019","volume":"70","author":"Jiao M.","year":"2014","unstructured":"Jiao M.; Ding C.; Zhang A.; Facile construction of 3-hydroxyphenanthrene-1,4-diones: Key intermediates to tanshinone I and its A-ring-modified analogue. Tetrahedron 2014,70,2976-2981","journal-title":"Tetrahedron"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1039\/C8OB00567B","volume":"16","author":"Wang F.","year":"2018","unstructured":"Wang F.; Yang H.; Yu S.; Xue Y.; Fan Z.; Liang G.; Geng M.; Zhang A.; Ding C.; Total synthesis of (\u00b1)-tanshinol B, tanshinone I, and (\u00b1)-tanshindiol B and C. Org Biomol Chem 2018,16(18),3376-3381","journal-title":"Org Biomol Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/10286020.2015.1136906","volume":"18","author":"Yang H.R.","year":"2016","unstructured":"Yang H.R.; Wang J.J.; Shao P.P.; Yuan S.Y.; Li X.Q.; A facile three-step total synthesis of tanshinone I. J Asian Nat Prod Res 2016,18(7),677-683","journal-title":"J Asian Nat Prod Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1021\/acs.jnatprod.7b00238","volume":"80","author":"Wu N.","year":"2017","unstructured":"Wu N.; Ma W.C.; Mao S.J.; Wu Y.; Jin H.; Total synthesis of tanshinone I. J Nat Prod 2017,80(5),1697-1700","journal-title":"J Nat Prod"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1016\/j.bmcl.2012.05.014","volume":"22","author":"Bi Y.F.","year":"2012","unstructured":"Bi Y.F.; Wang Z.J.; Guan R.F.; Ye Y.T.; Chen Y.Y.; Zhang Y.B.; Liu H.M.; Design, synthesis and vasodilative activity of tanshinone IIA derivatives. Bioorg Med Chem Lett 2012,22(15),5141-5143","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1021\/acs.jnatprod.6b00370","volume":"79","author":"Ding C.","year":"2016","unstructured":"Ding C.; Li J.; Jiao M.; Zhang A.; Catalyst-free sp3 C-H acyloxylation: regioselective synthesis of 1-acyloxy derivatives of the natural product tanshinone IIA. J Nat Prod 2016,79(10),2514-2520","journal-title":"J Nat Prod"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.tetlet.2017.03.078","volume":"58","author":"Liang B.","year":"2017","unstructured":"Liang B.; Yu S.; Li J.; Wang F.; Liang G.; Zhang A.; Ding C.; Site-selective Csp3-H aryloxylation of natural product tanshinone IIA and its analogues. Tetrahedron Lett 2017,58,1822-1825","journal-title":"Tetrahedron Lett"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"10488","DOI":"10.1021\/acs.jmedchem.8b01018","volume":"61","author":"Wu Q.","year":"2018","unstructured":"Wu Q.; Zheng K.; Huang X.; Li L.; Mei W.; Tanshinone-IIA-based analogues of imidazole alkaloid act as potent inhibitors to block breast cancer invasion and metastasis in vivo. J Med Chem 2018,61(23),10488-10501","journal-title":"J Med Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.tetlet.2017.11.046","volume":"59","author":"Li M.M.","year":"2018","unstructured":"Li M.M.; Xia F.; Li C.J.; Xu G.; Qin H.B.; Design, synthesis and cytotoxicity of nitrogen-containing tanshinone derivatives. Tetrahedron Lett 2018,59,46-48","journal-title":"Tetrahedron Lett"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1080\/00397911.2017.1378359","volume":"47","author":"Liu X.W.","year":"2017","unstructured":"Liu X.W.; Chen Z.Y.; Wang G.L.; Ma X.T.; Gong Y.; Liu X.L.; Feng T.T.; Zhou, Ying. Diversity-oriented TsOH catalysis-enabled construction of tanshinone-substituted bis(indolyl\/pyrrolyl) methanes and their biological evaluation for anticancer activities. Synth Commun 2017,47,2378-2386","journal-title":"Synth Commun"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"7388","DOI":"10.1021\/acs.joc.7b01064","volume":"82","author":"Li J.","year":"2017","unstructured":"Li J.; Xue Y.; Fan Z.; Ding C.; Zhang A.; Difluorination of Furonaphthoquinones. J Org Chem 2017,82(14),7388-7393","journal-title":"J Org Chem"},{"key":"ref=20","first-page":"1127","author":"Marrero J.G.","year":"2007","unstructured":"Marrero J.G.; San Andres L.; Luis. J.G. Oxidative C-ring opening of abietane diterpenes with ammonium cerium (IV) nitrate. Synlett 2007,1127-1129","journal-title":"Synlett"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1021\/ol400164e","volume":"15","author":"Zhang D.L.","year":"2013","unstructured":"Zhang D.L.; Zhou L.Y.; Quan J.M.; Zhang W.; Gu L.Q.; Huang Z.S.; An L.K.; Oxygen insertion of o-quinone under catalytic hydrogenation conditions. Org Lett 2013,15(6),1162-1165","journal-title":"Org Lett"},{"key":"ref=22","first-page":"163","volume":"69","author":"Li X.B.","year":"2014","unstructured":"Li X.B.; Cheng X.; Zhang D.L.; Wu H.Q.; Ye J.T.; Du J.; Huang Z.S.; Gu L.Q.; An L.K.; Syntheses of tanshinone anhydrides and their suppression on oxidized LDL uptake in macrophages and foam cell formation. Pharmazie 2014,69(3),163-167","journal-title":"Pharmazie"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.chroma.2013.02.055","volume":"1288","author":"Chen S.","year":"2013","unstructured":"Chen S.; Zhao X.; Li Y.; Yang D.; Zhou T.; Fan G.; Impurities preparation of sodium tanshinone IIA sulfonate by high-speed counter-current chromatography and identification by liquid chromatography\/multistage tandem mass spectrometry. J Chromatogr A 2013,1288,28-34","journal-title":"J Chromatogr A"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1016\/j.bmcl.2010.06.076","volume":"20","author":"Bi Y.F.","year":"2010","unstructured":"Bi Y.F.; Xu H.W.; Liu X.Q.; Zhang X.J.; Wang Z.J.; Liu H.M.; Synthesis and vasodilative activity of tanshinone IIA derivatives. Bioorg Med Chem Lett 2010,20(16),4892-4894","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.resmic.2016.08.002","volume":"168","author":"Wang D.","year":"2017","unstructured":"Wang D.; Lu C.; Sun F.; Cui M.; Mu H.; Duan J.; Geng H.; A tanshinone I derivative enhances the activities of antibiotics against Staphylococcus aureus in vitro and in vivo. Res Microbiol 2017,168(1),46-54","journal-title":"Res Microbiol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1016\/j.tetlet.2015.04.040","volume":"56","author":"Jiao M.","year":"2015","unstructured":"Jiao M.; Ding C.; Zhang A.; Preparation of 2-aryl derivatives of tanshinone I through a palladium-catalyzed Csp2\u2013H activation\/arylation approach. Tetrahedron Lett 2015,56,2799-2802","journal-title":"Tetrahedron Lett"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"10627","DOI":"10.1039\/C3RA45146A","volume":"4","author":"Rico-Mart\u00ednez M.","year":"2014","unstructured":"Rico-Mart\u00ednez M.; Medina F.G.; Marrero J.G.; Osegueda-Robles S.; Biotransformation of diterpenes. RSC Advances 2014,4,10627-10647","journal-title":"RSC Advances"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"8349","DOI":"10.1007\/s00253-016-7488-6","volume":"100","author":"He W.","year":"2016","unstructured":"He W.; Liu M.; Li X.; Zhang X.; Abdel-Mageed W.M.; Li L.; Wang W.; Zhang J.; Han J.; Dai H.; Quinn R.J.; Liu H.W.; Luo H.; Zhang L.; Liu X.; Fungal biotransformation of tanshinone results in [4+2] cycloaddition with sorbicillinol: evidence for enzyme catalysis and increased antibacterial activity. Appl Microbiol Biotechnol 2016,100(19),8349-8357","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=29","first-page":"442","volume":"6","author":"Wu L.","year":"2014","unstructured":"Wu L.; Yang X.; Synthesis and cytotoxic activity of tanshinone I derivatives having azacyclo moiety. J Chem Pharm Res 2014,6,442-445","journal-title":"J Chem Pharm Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"Siegel R.L.","year":"2019","unstructured":"Siegel R.L.; Miller K.D.; Jemal A.; Cancer statistics, 2019. CA Cancer J Clin 2019,69(1),7-34","journal-title":"CA Cancer J Clin"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"Holohan C.","year":"2013","unstructured":"Holohan C.; Van Schaeybroeck S.; Longley D.B.; Johnston P.G.; Cancer drug resistance: An evolving paradigm. Nat Rev Cancer 2013,13(10),714-726","journal-title":"Nat Rev Cancer"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.12659\/MSM.914446","volume":"25","author":"Xue J.","year":"2019","unstructured":"Xue J.; Jin X.; Wan X.; Yin X.; Fang M.; Liu T.; Zhao S.; Effects and mechanism of Tanshinone IIA in proliferation, apoptosis, and migration of human colon cancer cells. Med Sci Monit 2019,25,4793-4800","journal-title":"Med Sci Monit"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1002\/ptr.6392","volume":"33","author":"Liao X.Z.","year":"2019","unstructured":"Liao X.Z.; Gao Y.; Huang S.; Chen Z.Z.; Sun L.L.; Liu J.H.; Chen H.R.; Yu L.; Zhang J.X.; Lin L.Z.; Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase\/Akt signalling pathway. Phytother Res 2019,33(9),2298-2309","journal-title":"Phytother Res"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2374565","author":"He S.","year":"2019","unstructured":"He S.; Wang M.; Zhang Y.; Luo J.; Zhang Y.; Monitoring the early response of fulvestrant plus tanshinone IIA combination therapy to estrogen receptor-positive breast cancer by longitudinal 18F-FES PET\/CT. Contrast Media Mol Imaging 2019","journal-title":"Contrast Media Mol Imaging"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12918-018-0606-6","volume":"12","author":"Cao Y.F.","year":"2018","unstructured":"Cao Y.F.; Wang S.F.; Li X.; Zhang Y.L.; Qiao Y.J.; The anticancer mechanism investigation of Tanshinone IIA by pharmacological clustering in protein network. BMC Syst Biol 2018,12(1),90","journal-title":"BMC Syst Biol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.biopha.2018.06.028","volume":"105","author":"Qin J.","year":"2018","unstructured":"Qin J.; Shi H.; Xu Y.; Zhao F.; Wang Q.; Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity. Biomed Pharmacother 2018,105,758-765","journal-title":"Biomed Pharmacother"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41419-017-0247-5","volume":"9","author":"Lv C.","year":"2018","unstructured":"Lv C.; Zeng H.W.; Wang J.X.; Yuan X.; Zhang C.; Fang T.; Yang P.M.; Wu T.; Zhou Y.D.; Nagle D.G.; Zhang W.D.; The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG. Cell Death Dis 2018,9(2),165","journal-title":"Cell Death Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1186\/s12885-016-2921-x","volume":"16","author":"Xie J.","year":"2016","unstructured":"Xie J.; Liu J.H.; Liu H.; Liao X.Z.; Chen Y.; Lin M.G.; Gu Y.Y.; Liu T.L.; Wang D.M.; Ge H.; Mo S.L.; Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way. BMC Cancer 2016,16(1),899","journal-title":"BMC Cancer"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2147\/OTT.S161534","volume":"11","author":"Chiu C.M.","year":"2018","unstructured":"Chiu C.M.; Huang S.Y.; Chang S.F.; Liao K.F.; Chiu S.C.; Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells. OncoTargets Ther 2018,11,1777-1785","journal-title":"OncoTargets Ther"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1055\/s-0033-1360126","volume":"80","author":"Kan S.","year":"2014","unstructured":"Kan S.; Cheung W.M.; Zhou Y.; Ho W.S.; Enhancement of doxorubicin cytotoxicity by tanshinone IIA in HepG2 human hepatoma cells. Planta Med 2014,80(1),70-76","journal-title":"Planta Med"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/ptr.6353","volume":"33","author":"Li K.","year":"2019","unstructured":"Li K.; Liu W.; Zhao Q.; Wu C.; Fan C.; Lai H.; Li S.; Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer. Phytother Res 2019,33(6),1658-1669","journal-title":"Phytother Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3892\/etm.2016.2984","volume":"11","author":"Bai Y.","year":"2016","unstructured":"Bai Y.; Zhang L.; Fang X.; Yang Y.; Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-\u03baB. Exp Ther Med 2016,11(3),1085-1089","journal-title":"Exp Ther Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.apjtm.2016.09.003","volume":"9","author":"Li Q.","year":"2016","unstructured":"Li Q.; Hu K.; Tang S.; Xu L.F.; Luo Y.C.; Anti-tumor activity of tanshinone IIA in combined with cyclophosphamide against Lewis mice with lung cancer. Asian Pac J Trop Med 2016,9(11),1084-1088","journal-title":"Asian Pac J Trop Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00262-019-02326-8","volume":"68","author":"Liu S.","year":"2019","unstructured":"Liu S.; Han Z.; Trivett A.L.; Lin H.; Hannifin S.; Yang D.; Oppenheim J.J.; Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma. Cancer Immunol Immunother 2019,68(7),1059-1071","journal-title":"Cancer Immunol Immunother"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.intimp.2003.12.003","volume":"4","author":"Wong C.K.","year":"2004","unstructured":"Wong C.K.; Tse P.S.; Wong E.L.; Leung P.C.; Fung K.P.; Lam C.W.; Immunomodulatory effects of yun zhi and danshen capsules in health subjects--a randomized, double-blind, placebo-controlled, crossover study. Int Immunopharmacol 2004,4(2),201-211","journal-title":"Int Immunopharmacol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1142\/S0192415X05002990","volume":"33","author":"Wong C.K.","year":"2005","unstructured":"Wong C.K.; Bao Y.X.; Wong E.L.; Leung P.C.; Fung K.P.; Lam C.W.; Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am J Chin Med 2005,33(3),381-395","journal-title":"Am J Chin Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00280-016-3034-6","volume":"77","author":"Jing X.","year":"2016","unstructured":"Jing X.; Xu Y.; Cheng W.; Guo S.; Zou Y.; He L.; Tanshinone I induces apoptosis and pro-survival autophagy in gastric cancers. Cancer Chemother Pharmacol 2016,77(6),1171-1181","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.intimp.2018.10.035","volume":"65","author":"Zhang L.","year":"2018","unstructured":"Zhang L.; Chen C.; Duanmu J.; Wu Y.; Tao J.; Yang A.; Yin X.; Xiong B.; Gu J.; Li C.; Liu Z.; Cryptotanshinone inhibits the growth and invasion of colon cancer by suppressing inflammation and tumor angiogenesis through modulating MMP\/TIMP system, PI3K\/Akt\/mTOR signaling and HIF-1\u03b1 nuclear translocation. Int Immunopharmacol 2018,65,429-437","journal-title":"Int Immunopharmacol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","volume":"26","author":"Jain R.K.","year":"2014","unstructured":"Jain R.K.; Antiangiogenesis strategies revisited: From starving tumors to alleviating hypoxia. Cancer Cell 2014,26(5),605-622","journal-title":"Cancer Cell"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fonc.2018.00248","volume":"8","author":"Zuazo-Gaztelu I.","year":"2018","unstructured":"Zuazo-Gaztelu I.; Casanovas O.; Unraveling the role of angiogenesis in cancer ecosystems. Front Oncol 2018,8,248","journal-title":"Front Oncol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"16031","DOI":"10.18632\/oncotarget.3648","volume":"6","author":"Wang Y.","year":"2015","unstructured":"Wang Y.; Li J.X.; Wang Y.Q.; Miao Z.H.; Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1\u03b1 accumulation in both endothelial and tumor cells. Oncotarget 2015,6(18),16031-16042","journal-title":"Oncotarget"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117440","volume":"10","author":"Li G.","year":"2015","unstructured":"Li G.; Shan C.; Liu L.; Zhou T.; Zhou J.; Hu X.; Chen Y.; Cui H.; Gao N.; Tanshinone IIA inhibits HIF-1\u03b1 and VEGF expression in breast cancer cells via mTOR\/p70S6K\/RPS6\/4E-BP1 signaling pathway. PLoS One 2015,10(2)","journal-title":"PLoS One"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2017.05.013","volume":"403","author":"Sui H.","year":"2017","unstructured":"Sui H.; Zhao J.; Zhou L.; Wen H.; Deng W.; Li C.; Ji Q.; Liu X.; Feng Y.; Chai N.; Zhang Q.; Cai J.; Li Q.; Tanshinone IIA inhibits \u03b2-catenin\/VEGF-mediated angiogenesis by targeting TGF-\u03b21 in normoxic and HIF-1\u03b1 in hypoxic microenvironments in human colorectal cancer. Cancer Lett 2017,403,86-97","journal-title":"Cancer Lett"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3892\/or.2014.3592","volume":"33","author":"Xing Y.","year":"2015","unstructured":"Xing Y.; Tu J.; Zheng L.; Guo L.; Xi T.; Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF\/VEGFR2 pathway in vascular endothelial cells. Oncol Rep 2015,33(1),163-170","journal-title":"Oncol Rep"},{"key":"ref=55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100416","volume":"9","author":"Zhang Z.R.","year":"2014","unstructured":"Zhang Z.R.; Li J.H.; Li S.; Liu A.L.; Hoi P.M.; Tian H.Y.; Ye W.C.; Lee S.M.Y.; Jiang R.W.; In vivo angiogenesis screening and mechanism of action of novel tanshinone derivatives produced by one-pot combinatorial modification of natural tanshinone mixture from Salvia miltiorrhiza. PLoS One 2014,9(7)","journal-title":"PLoS One"},{"key":"ref=56","first-page":"351","volume":"11","author":"Wu P.","year":"2019","unstructured":"Wu P.; Du Y.; Xu Z.; Zhang S.; Liu J.; Aa N.; Yang Z.; Protective effects of sodium tanshinone IIA sulfonate on cardiac function after myocardial infarction in mice. Am J Transl Res 2019,11(1),351-360","journal-title":"Am J Transl Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.bbrc.2019.09.106","volume":"520","author":"Chen L.","year":"2019","unstructured":"Chen L.; He W.; Peng B.; Yuan M.; Wang N.; Wang J.; Lu W.; Wang T.; Sodium Tanshinone IIA sulfonate improves post-ischemic angiogenesis in hyperglycemia. Biochem Biophys Res Commun 2019,520(3),580-585","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"Heneka M.T.","year":"2015","unstructured":"Heneka M.T.; Carson M.J.; El Khoury J.; Landreth G.E.; Brosseron F.; Feinstein D.L.; Jacobs A.H.; Wyss-Coray T.; Vitorica J.; Ransohoff R.M.; Herrup K.; Frautschy S.A.; Finsen B.; Brown G.C.; Verkhratsky A.; Yamanaka K.; Koistinaho J.; Latz E.; Halle A.; Petzold G.C.; Town T.; Morgan D.; Shinohara M.L.; Perry V.H.; Holmes C.; Bazan N.G.; Brooks D.J.; Hunot S.; Joseph B.; Deigendesch N.; Garaschuk O.; Boddeke E.; Dinarello C.A.; Breitner J.C.; Cole G.M.; Golenbock D.T.; Kummer M.P.; Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 2015,14(4),388-405","journal-title":"Lancet Neurol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/jphp.12650","volume":"69","author":"Zhu J.","year":"2017","unstructured":"Zhu J.; Liao S.; Zhou L.; Wan L.; Tanshinone IIA attenuates A\u03b225-35 -induced spatial memory impairment via upregulating receptors for activated C kinase1 and inhibiting autophagy in hippocampus. J Pharm Pharmacol 2017,69(2),191-201","journal-title":"J Pharm Pharmacol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/WNR.0000000000000419","volume":"26","author":"Li J.","year":"2015","unstructured":"Li J.; Wen P.Y.; Li W.W.; Zhou J.; Upregulation effects of Tanshinone IIA on the expressions of NeuN, Nissl body, and I\u03baB and downregulation effects on the expressions of GFAP and NF-\u03baB in the brain tissues of rat models of Alzheimer\u2019s disease. Neuroreport 2015,26(13),758-766","journal-title":"Neuroreport"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neulet.2016.11.024","volume":"637","author":"Kong D.","year":"2017","unstructured":"Kong D.; Liu Q.; Xu G.; Huang Z.; Luo N.; Huang Y.; Cai K.; Synergistic effect of tanshinone IIA and mesenchymal stem cells on preventing learning and memory deficits via anti-apoptosis, attenuating tau phosphorylation and enhancing the activity of central cholinergic system in vascular dementia. Neurosci Lett 2017,637,175-181","journal-title":"Neurosci Lett"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbr.2019.03.001","volume":"365","author":"Huang N.","year":"2019","unstructured":"Huang N.; Li Y.; Zhou Y.; Zhou Y.; Feng F.; Shi S.; Ba Z.; Luo Y.; Neuroprotective effect of tanshinone IIA-incubated mesenchymal stem cells on A\u03b225-35-induced neuroinflammation. Behav Brain Res 2019,365,48-55","journal-title":"Behav Brain Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neulet.2017.08.059","volume":"659","author":"Li M.","year":"2017","unstructured":"Li M.; Wang J.; Ding L.; Meng H.; Wang F.; Luo Z.; Tanshinone IIA attenuates nerve transection injury associated with nerve regeneration promotion in rats. Neurosci Lett 2017,659,18-25","journal-title":"Neurosci Lett"},{"key":"ref=64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202532","volume":"13","author":"Wang Z.","year":"2018","unstructured":"Wang Z.; Yang X.; Zhang W.; Zhang P.; Jiang B.; Tanshinone IIA attenuates nerve structural and functional damage induced by nerve crush injury in rats. PLoS One 2018,13(8)","journal-title":"PLoS One"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.phytol.2018.05.016","volume":"26","author":"Cao G.Y.","year":"2018","unstructured":"Cao G.Y.; Wang X.H.; Li K.K.; Zhao A.H.; Shen L.; Yua D.N.; Neuroprotective effects of cryptotanshinone and 1,2-dihydrotanshinone I against MPTP induced mouse model of Parkinson\u2019s disease. Phytochem Lett 2018,26,68-73","journal-title":"Phytochem Lett"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jep.2015.01.042","volume":"164","author":"Wang S.","year":"2015","unstructured":"Wang S.; Jing H.; Yang H.; Liu Z.; Guo H.; Chai L.; Hu L.; Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson\u2019s disease. J Ethnopharmacol 2015,164,247-255","journal-title":"J Ethnopharmacol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13195-018-0457-9","volume":"10","author":"Dou K.X.","year":"2018","unstructured":"Dou K.X.; Tan M.S.; Tan C.C.; Cao X.P.; Hou X.H.; Guo Q.H.; Tan L.; Mok V.; Yu J.T.; Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: a network meta-analysis of 41 randomized controlled trials. Alzheimers Res Ther 2018,10(1),126","journal-title":"Alzheimers Res Ther"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-2004-815535","volume":"70","author":"Ren Y.","year":"2004","unstructured":"Ren Y.; Houghton P.J.; Hider R.C.; Howes M.J.; Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorhiza. Planta Med 2004,70(3),201-204","journal-title":"Planta Med"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1021\/cn400051e","volume":"4","author":"Wang Q.","year":"2013","unstructured":"Wang Q.; Yu X.; Patal K.; Hu R.; Chuang S.; Zhang G.; Zheng J.; Tanshinones inhibit amyloid aggregation by amyloid-\u03b2 peptide, disaggregate amyloid fibrils, and protect cultured cells. ACS Chem Neurosci 2013,4(6),1004-1015","journal-title":"ACS Chem Neurosci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.etap.2011.02.006","volume":"31","author":"Zhou Y.","year":"2011","unstructured":"Zhou Y.; Li W.; Xu L.; Chen L.; In Salvia miltiorrhiza, phenolic acids possess protective properties against amyloid \u03b2-induced cytotoxicity, and tanshinones act as acetylcholinesterase inhibitors. Environ Toxicol Pharmacol 2011,31(3),443-452","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejphar.2007.07.042","volume":"574","author":"Kim D.H.","year":"2007","unstructured":"Kim D.H.; Jeon S.J.; Jung J.W.; Lee S.; Yoon B.H.; Shin B.Y.; Son K.H.; Cheong J.H.; Kim Y.S.; Kang S.S.; Ko K.H.; Ryu J.H.; Tanshinone congeners improve memory impairments induced by scopolamine on passive avoidance tasks in mice. Eur J Pharmacol 2007,574(2-3),140-147","journal-title":"Eur J Pharmacol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cbi.2010.03.026","volume":"187","author":"Wong K.K.","year":"2010","unstructured":"Wong K.K.; Ngo J.C.; Liu S.; Lin H.Q.; Hu C.; Shaw P.C.; Wan D.C.; Interaction study of two diterpenes, cryptotanshinone and dihydrotanshinone, to human acetylcholinesterase and butyrylcholinesterase by molecular docking and kinetic analysis. Chem Biol Interact 2010,187(1-3),335-339","journal-title":"Chem Biol Interact"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1021\/np800318m","volume":"71","author":"Pejin B.","year":"2008","unstructured":"Pejin B.; Iodice C.; Tommonaro G.; De Rosa S.; Synthesis and biological activities of thio-avarol derivatives. J Nat Prod 2008,71(11),1850-1853","journal-title":"J Nat Prod"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3109\/14756366.2015.1057724","volume":"31","author":"Tommonaro G.","year":"2016","unstructured":"Tommonaro G.; Pejin B.; Iodice C.; Tafuto A.; De Rosa S.; Further in vitro biological activity evaluation of amino-, thio- and ester-derivatives of avarol. J Enzyme Inhib Med Chem 2016,31(4),684-686","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ejmech.2016.06.036","volume":"122","author":"Tommonaro G.","year":"2016","unstructured":"Tommonaro G.; Garc\u00eda-Font N.; Vitale R.M.; Pejin B.; Iodice C.; Ca\u00f1adas S.; Marco-Contelles J.; Oset-Gasque M.J.; Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer\u2019s disease. Eur J Med Chem 2016,122,326-338","journal-title":"Eur J Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.amjmed.2014.10.047","volume":"128","author":"Milani R.V.","year":"2015","unstructured":"Milani R.V.; Lavie C.J.; Health care 2020: reengineering health care delivery to combat chronic disease. Am J Med 2015,128(4),337-343","journal-title":"Am J Med"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"17451","DOI":"10.1038\/s41598-017-16980-4","volume":"7","author":"Li S.","year":"2017","unstructured":"Li S.; Jiao Y.; Wang H.; Shang Q.; Lu F.; Huang L.; Liu J.; Xu H.; Chen K.; Sodium tanshinone IIA sulfate adjunct therapy reduces high-sensitivity C-reactive protein level in coronary artery disease patients: A randomized controlled trial. Sci Rep 2017,7(1),17451","journal-title":"Sci Rep"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"10161","DOI":"10.18632\/oncotarget.14328","volume":"8","author":"Feng J.","year":"2017","unstructured":"Feng J.; Chen H.W.; Pi L.J.; Wang J.; Zhan D.Q.; Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C\/Wnt signaling pathway. Oncotarget 2017,8(6),10161-10170","journal-title":"Oncotarget"},{"key":"ref=79","doi-asserted-by":"publisher","DOI":"10.1093\/ecam\/nep056","author":"Chan P.","year":"2011","unstructured":"Chan P.; Liu I.M.; Li Y.X.; Yu W.J.; Cheng J.T.; Antihypertension induced by tanshinone IIA isolated from the roots of Salvia miltiorrhiza. Evid Based Complement Alternat Med 2011","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/10286020.2017.1337751","volume":"20","author":"Qin Y.L.","year":"2018","unstructured":"Qin Y.L.; Chen L.; He W.; Su M.; Jin Q.; Fang Z.; Ouyang P.K.; Guo K.; Continuous synthesis and anti-myocardial injury of tanshinone IIA derivatives. J Asian Nat Prod Res 2018,20(2),139-147","journal-title":"J Asian Nat Prod Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1021\/acsami.8b20158","volume":"11","author":"Wang W.","year":"2019","unstructured":"Wang W.; Chen J.; Li M.; Jia H.; Han X.; Zhang J.; Zou Y.; Tan B.; Liang W.; Shang Y.; Xu Q.A.S.; Wang W.; Mao J.; Gao X.; Fan G.; Liu W.; Rebuilding postinfarcted cardiac functions by injecting TIIA@PDA nanoparticle-cross-linked ROS-sensitive hydrogels. ACS Appl Mater Interfaces 2019,11(3),2880-2890","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yjmcc.2019.09.012","volume":"137","author":"Gao S.","year":"2019","unstructured":"Gao S.; Li L.; Li L.; Ni J.; Guo R.; Mao J.; Fan G.; Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice. J Mol Cell Cardiol 2019,137,59-70","journal-title":"J Mol Cell Cardiol"},{"key":"ref=83","first-page":"1794","volume":"6","author":"Zhang H.","year":"2014","unstructured":"Zhang H.; Long M.; Wu Z.; Han X.; Yu Y.; Sodium tanshinone IIA silate as an add-on therapy in patients with unstable angina pectoris. J Thorac Dis 2014,6(12),1794-1799","journal-title":"J Thorac Dis"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.2147\/IJN.S165590","volume":"13","author":"Zhang S.","year":"2018","unstructured":"Zhang S.; Li J.; Hu S.; Wu F.; Zhang X.; Triphenylphosphonium and D-\u03b1-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction. Int J Nanomedicine 2018,13,4045-4057","journal-title":"Int J Nanomedicine"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ejphar.2016.09.041","volume":"791","author":"Feng J.","year":"2016","unstructured":"Feng J.; Li S.; Chen H.; Tanshinone IIA inhibits myocardial remodeling induced by pressure overload via suppressing oxidative stress and inflammation: Possible role of silent information regulator 1. Eur J Pharmacol 2016,791,632-639","journal-title":"Eur J Pharmacol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"19043","DOI":"10.1039\/C8NJ04819C","volume":"42","author":"Li Y.","year":"2018","unstructured":"Li Y.; An C.; Han D.; Dang Y.; Liu X.; Zhang F.; Xu Y.; Zhongd H.; Sun X.; Neutrophil affinity for PGP and HAIYPRH (T7) peptide dual-ligand functionalized nanoformulation enhances the brain delivery of tanshinone IIA and exerts neuroprotective effects against ischemic stroke by inhibiting proinflammatory signaling pathways. New J Chem 2018,42,19043-19061","journal-title":"New J Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1073\/pnas.1621375114","volume":"114","author":"Wernig G.","year":"2017","unstructured":"Wernig G.; Chen S.Y.; Cui L.; Van Neste C.; Tsai J.M.; Kambham N.; Vogel H.; Natkunam Y.; Gilliland D.G.; Nolan G.; Weissman I.L.; Unifying mechanism for different fibrotic diseases. Proc Natl Acad Sci USA 2017,114(18),4757-4762","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jep.2016.12.042","volume":"198","author":"Li L.C.","year":"2017","unstructured":"Li L.C.; Kan L.D.; Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects. J Ethnopharmacol 2017,198,45-63","journal-title":"J Ethnopharmacol"},{"key":"ref=89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129655","volume":"10","author":"Jiang X.","year":"2015","unstructured":"Jiang X.; Chen Y.; Zhu H.; Wang B.; Qu P.; Chen R.; Sun X.; Sodium tanshinone IIA sulfonate ameliorates bladder fibrosis in a rat model of partial bladder outlet obstruction by inhibiting the TGF-\u03b2\/Smad pathway activation. PLoS One 2015,10(6)","journal-title":"PLoS One"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.intimp.2015.02.027","volume":"26","author":"Wang D.T.","year":"2015","unstructured":"Wang D.T.; Huang R.H.; Cheng X.; Zhang Z.H.; Yang Y.J.; Lin X.; Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-\u03b2\/Smad and NF-\u03baB signaling pathway in 5\/6 nephrectomized rats. Int Immunopharmacol 2015,26(1),4-12","journal-title":"Int Immunopharmacol"},{"key":"ref=91","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/867140","author":"Jiang C.","year":"2015","unstructured":"Jiang C.; Shao Q.; Jin B.; Gong R.; Zhang M.; Xu B.; Tanshinone IIA attenuates renal fibrosis after acute kidney injury in a mouse model through inhibition of fibrocytes recruitment. BioMed Res Int 2015","journal-title":"BioMed Res Int"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.4314\/tjpr.v16i12.9","volume":"16","author":"Shao Q.","year":"2017","unstructured":"Shao Q.; Jiang C.; Sun C.; Zhu W.; Cao D.; Feng Y.; Zhang M.; Tanshinone IIA mitigates peritoneal fibrosis by inhibiting EMT via regulation of TGF-\u03b2\/smad pathway. Trop J Pharm Res 2017,16,2857-2864","journal-title":"Trop J Pharm Res"},{"key":"ref=93","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109586","author":"Feng F.","year":"2020","unstructured":"Feng F.; Li N.; Cheng P.; Zhang H.; Wang H.; Wang Y.; Wang W.; Tanshinone IIA attenuates silica-induced pulmonary fibrosis via inhibition of TGF-\u03b21-Smad signaling pathway. Biomed Pharmacother 2020","journal-title":"Biomed Pharmacother"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.3892\/mmr.2015.3333","volume":"11","author":"He H.","year":"2015","unstructured":"He H.; Tang H.; Gao L.; Wu Y.; Feng Z.; Lin H.; Wu T.; Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats. Mol Med Rep 2015,11(6),4190-4196","journal-title":"Mol Med Rep"},{"key":"ref=95","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6712585","author":"Chen T.","year":"2018","unstructured":"Chen T.; Li M.; Fan X.; Cheng J.; Wang L.; Sodium tanshinone IIA sulfonate prevents angiotensin II-Induced differentiation of human atrial fibroblasts into myofibroblasts. Oxid Med Cell Longev 2018","journal-title":"Oxid Med Cell Longev"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1038\/s41467-018-06514-5","volume":"9","author":"Jiang Q.","year":"2018","unstructured":"Jiang Q.; Li K.; Lu W.J.; Li S.; Chen X.; Liu X.J.; Yuan J.; Ding Q.; Lan F.; Cai S.Q.; Identification of small-molecule ion channel modulators in C. elegans channelopathy models. Nat Commun 2018,9(1),3941","journal-title":"Nat Commun"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.resp.2014.09.025","volume":"205","author":"Zheng L.","year":"2015","unstructured":"Zheng L.; Liu M.; Wei M.; Liu Y.; Dong M.; Luo Y.; Zhao P.; Dong H.; Niu W.; Yan Z.; Li Z.; Tanshinone IIA attenuates hypoxic pulmonary hypertension via modulating KV currents. Respir Physiol Neurobiol 2015,205,120-128","journal-title":"Respir Physiol Neurobiol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejphar.2017.09.047","volume":"815","author":"Zhu J.","year":"2017","unstructured":"Zhu J.; Xu Y.; Ren G.; Hu X.; Wang C.; Yang Z.; Li Z.; Mao W.; Lu D.; Tanshinone I.I.A.; Sodium sulfonate regulates antioxidant system, inflammation, and endothelial dysfunction in atherosclerosis by downregulation of CLIC1. Eur J Pharmacol 2017,815,427-436","journal-title":"Eur J Pharmacol"},{"key":"ref=99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178226","volume":"12","author":"Chen P.X.","year":"2017","unstructured":"Chen P.X.; Zhang Y.L.; Xu J.W.; Yu M.H.; Huang J.H.; Zhao L.; Zhou W.L.; Sodium tanshinone IIA sulfonate stimulated Cl- secretion in mouse trachea. PLoS One 2017,12(5)","journal-title":"PLoS One"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fphar.2018.00062","volume":"9","author":"Zhang X.D.","year":"2018","unstructured":"Zhang X.D.; He C.X.; Cheng J.; Wen J.; Li P.Y.; Wang N.; Li G.; Zeng X.R.; Cao J.M.; Yang Y.; Sodium tanshinone II-A sulfonate (DS-201) induces vasorelaxation of rat mesenteric arteries via inhibition of L-type Ca2+ channel. Front Pharmacol 2018,9,62","journal-title":"Front Pharmacol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ejphar.2019.04.049","volume":"854","author":"Zhou Y.","year":"2019","unstructured":"Zhou Y.; Liu X.; Zhang X.; Wen J.; Cheng J.; Li P.; Wang N.; Zhou X.; Xia D.; Yang Q.; Yang Y.; Decreased vasodilatory effect of Tanshinone IIA Sodium Sulfonate on mesenteric artery in hypertension. Eur J Pharmacol 2019,854,365-371","journal-title":"Eur J Pharmacol"},{"key":"ref=102","first-page":"624","volume":"83","author":"Zhang Y.L.","year":"2017","unstructured":"Zhang Y.L.; Xu J.W.; Wu X.H.; Chen P.X.; Wei F.; Gao D.D.; Chen X.W.; Luo Y.L.; Zhu Y.X.; Huang J.; Tan Y.X.; Zhao L.; Zhou W.L.; Relaxant effect of sodium tanshinone IIA sulphonate on mouse tracheal smooth muscle. Planta Med 2017,83(7),624-630","journal-title":"Planta Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jep.2013.03.045","volume":"147","author":"Lin T.Y.","year":"2013","unstructured":"Lin T.Y.; Lu C.W.; Huang S.K.; Wang S.J.; Tanshinone IIA, a constituent of Danshen, inhibits the release of glutamate in rat cerebrocortical nerve terminals. J Ethnopharmacol 2013,147(2),488-496","journal-title":"J Ethnopharmacol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/exd.13511","volume":"27","author":"Tang L.","year":"2018","unstructured":"Tang L.; He S.; Wang X.; Liu H.; Zhu Y.; Feng B.; Su Z.; Zhu W.; Liu B.; Xu F.; Li C.; Zhao J.; Zheng X.; Lu C.; Zheng G.; Cryptotanshinone reduces psoriatic epidermal hyperplasia via inhibiting the activation of STAT3. Exp Dermatol 2018,27(3),268-275","journal-title":"Exp Dermatol"},{"key":"ref=105","first-page":"4070","volume":"16","author":"Xu P.","year":"2018","unstructured":"Xu P.; Ji L.; Tian S.; Li F.; Clinical effects of tanshinone IIA sodium sulfonate combined with trimetazidine and levocarnitine in the treatment of AVMC and its effects on serum TNF-\u03b1, IL-18 and IL-35. Exp Ther Med 2018,16(5),4070-4074","journal-title":"Exp Ther Med"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1080\/14786419.2016.1138302","volume":"30","author":"Zeng L.W.","year":"2016","unstructured":"Zeng L.W.; Zhou C.X.; Liu J.D.; Liu C.H.; Mo J.X.; Hou A.F.; Yao W.; Wang Z.Z.; Gan L.S.; Design, synthesis, and antimicrobial activities of new tanshinone IIA esters. Nat Prod Res 2016,30(23),2662-2668","journal-title":"Nat Prod Res"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1124\/mol.107.034447","volume":"72","author":"Kim E.J.","year":"2007","unstructured":"Kim E.J.; Jung S.N.; Son K.H.; Kim S.R.; Ha T.Y.; Park M.G.; Jo I.G.; Park J.G.; Choe W.; Kim S.S.; Ha J.; Antidiabetes and antiobesity effect of cryptotanshinone via activation of AMP-activated protein kinase. Mol Pharmacol 2007,72(1),62-72","journal-title":"Mol Pharmacol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.phymed.2015.12.004","volume":"23","author":"Rahman N.","year":"2016","unstructured":"Rahman N.; Jeon M.; Song H.Y.; Kim Y.S.; Cryptotanshinone, a compound of Salvia miltiorrhiza inhibits pre-adipocytes differentiation by regulation of adipogenesis-related genes expression via STAT3 signaling. Phytomedicine 2016,23(1),58-67","journal-title":"Phytomedicine"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14786419.2019.1607337","author":"Marrelli M.","year":"2019","unstructured":"Marrelli M.; Grande F.; Occhiuzzi M.A.; Maione F.; Mascolo N.; Conforti F.; Cryptotanshinone and tanshinone IIA from Salvia milthorrhiza Bunge (Danshen) as a new class of potential pancreatic lipase inhibitors. Nat Prod Res 2019,1-4","journal-title":"Nat Prod Res"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1124\/jpet.105.100701","volume":"317","author":"Zhang J.","year":"2006","unstructured":"Zhang J.; Huang M.; Guan S.; Bi H.C.; Pan Y.; Duan W.; Chan S.Y.; Chen X.; Hong Y.H.; Bian J.S.; Yang H.Y.; Zhou S.; A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza. J Pharmacol Exp Ther 2006,317(3),1285-1294","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1142\/S0192415X13500146","volume":"41","author":"Ma H.","year":"2013","unstructured":"Ma H.; Fan Q.; Yu J.; Xin J.; Zhang C.; Novel microemulsion of tanshinone IIA, isolated from Salvia miltiorrhiza Bunge, exerts anticancer activity through inducing apoptosis in hepatoma cells. Am J Chin Med 2013,41(1),197-210","journal-title":"Am J Chin Med"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1039\/C5BM00224A","volume":"4","author":"Chen F.","year":"2016","unstructured":"Chen F.; Zhang J.; He Y.; Fang X.; Wang Y.; Chen M.; Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA. Biomater Sci 2016,4(1),167-182","journal-title":"Biomater Sci"},{"key":"ref=113","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/27\/49\/495101","volume":"27","author":"Lee W.D.","year":"2016","unstructured":"Lee W.D.; Liang Y.J.; Chen B.H.; Effects of tanshinone nanoemulsion and extract on inhibition of lung cancer cells A549. Nanotechnology 2016,27(49)","journal-title":"Nanotechnology"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s11434-016-1046-6","volume":"61","author":"Yu L.","year":"2016","unstructured":"Yu L.; Cheng J.; Huang W.J.; Tan X.Q.; Mao L.; Liu Z.F.; Zeng X.R.; Yang Y.; Liposome intracellular delivery of Salvia miltiorrhiza Bge. deprivative DS-201 improves its BKCa channel-activating and vasorelaxing effects. Sci Bull (Beijing) 2016,61,622-631","journal-title":"Sci Bull (Beijing)"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jddst.2018.10.024","volume":"48","author":"Shu C.","year":"2018","unstructured":"Shu C.; Li T.; Li D.; Zhu Y.; Tang Y.; Kong Y.; Yang Z.; liu, M.; Gu, M.; Ding, L. Anticancer activity and pharmacokinetics of TanshinoneIIA derivative supramolecular hydrogels. J Drug Deliv Sci Technol 2018,48,509-515","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1039\/C6CC08502D","volume":"53","author":"Yin Y.","year":"2017","unstructured":"Yin Y.; Wu C.; Wang J.; Song F.; Yue W.; Zhong W.; A simply triggered peptide-based hydrogel as an injectable nanocarrier of tanshinone IIA and tanshinones. Chem Commun (Camb) 2017,53(3),529-532","journal-title":"Chem Commun (Camb)"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.biochi.2016.07.008","volume":"128-129","author":"Jeevanandam J.","year":"2016","unstructured":"Jeevanandam J.; Chan Y.S.; Danquah M.K.; Nano-formulations of drugs: Recent developments, impact and challenges. Biochimie 2016,128-129,99-112","journal-title":"Biochimie"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.bmcl.2016.03.097","volume":"26","author":"Qiu S.","year":"2016","unstructured":"Qiu S.; Granet R.; Mbakidi J.P.; Br\u00e9gier F.; Pouget C.; Micallef L.; Sothea-Ouk T.; Leger D.Y.; Liagre B.; Chaleix V.; Sol V.; Delivery of tanshinone IIA and \u03b1-mangostin from gold\/PEI\/cyclodextrin nanoparticle platform designed for prostate cancer chemotherapy. Bioorg Med Chem Lett 2016,26(10),2503-2506","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=119","first-page":"1421","volume":"44","author":"Zhang W.L.","year":"2009","unstructured":"Zhang W.L.; Liu J.P.; Liu X.X.; Chen Z.Q.; Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats. Yao Xue Xue Bao 2009,44(12),1421-1428","journal-title":"Yao Xue Xue Bao"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1208\/s12249-010-9410-3","volume":"11","author":"Hu L.","year":"2010","unstructured":"Hu L.; Xing Q.; Meng J.; Shang C.; Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles. AAPS PharmSciTech 2010,11(2),582-587","journal-title":"AAPS PharmSciTech"},{"key":"ref=121","doi-asserted-by":"publisher","author":"Mao S.","unstructured":"Mao S.; Wang L.; Chen P.; Lan Y.; Guo R.; Zhang M.;  Nanoparticle- mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: Role of NF-\u03baB pathway. Artif. Cells Nanomed. Biotechnol., 2018, 46(sup3), S707-S716.","DOI":"10.1080\/21691401.2018.1508028"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejps.2015.03.002","volume":"73","author":"Meng Z.","year":"2015","unstructured":"Meng Z.; Meng L.; Wang K.; Li J.; Cao X.; Wu J.; Hu Y.; Enhanced hepatic targeting, biodistribution and antifibrotic efficacy of tanshinone IIA loaded globin nanoparticles. Eur J Pharm Sci 2015,73,35-43","journal-title":"Eur J Pharm Sci"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/181480","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/181480\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/181480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T09:29:15Z","timestamp":1638696555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/181480\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557520666200429103225","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-10-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}